Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
38204
CAS Number:
146464-95-1
Pralatrexate
Purity:
≥ 98% (HPLC)
Synonym(s):
(2S)-2-[4-[1-(2,4-Diaminopteridin-6-yl)pent-4-yn-2-yl]benzamido]pentanedioicacid
Documents
$209.61 /25MG
Pack Size Availability Price
Request Bulk Quote
Product Information

Pralatrexate is a potent antifolate agent primarily utilized in the treatment of certain types of lymphomas, particularly peripheral T-cell lymphoma. This compound functions by inhibiting dihydrofolate reductase, an enzyme critical for DNA synthesis and cell division, making it a valuable therapeutic option in oncology. Its unique structure allows for enhanced cellular uptake, which significantly improves its efficacy compared to other antifolates. Researchers and healthcare professionals appreciate Pralatrexate for its ability to overcome resistance mechanisms often seen with traditional chemotherapy agents, thus providing a viable alternative for patients with relapsed or refractory conditions.

In addition to its primary use in cancer treatment, Pralatrexate is also being explored in combination therapies to enhance the effectiveness of existing treatment regimens. Its application in clinical settings demonstrates its potential to improve patient outcomes, particularly in those who have not responded to other therapies. With ongoing research, the versatility of Pralatrexate continues to expand, making it a compound of interest for both pharmaceutical development and clinical practice.

Synonyms
(2S)-2-[4-[1-(2,4-Diaminopteridin-6-yl)pent-4-yn-2-yl]benzamido]pentanedioicacid
CAS Number
146464-95-1
Purity
≥ 98% (HPLC)
Molecular Formula
C23H23N7O5
Molecular Weight
477.48
MDL Number
MFCD00920897
PubChem ID
18350668
Melting Point
215 °C (dec.)
Appearance
White to light yellow powder to crystal
Conditions
Store at 2 - 8 °C
General Information
Synonyms
(2S)-2-[4-[1-(2,4-Diaminopteridin-6-yl)pent-4-yn-2-yl]benzamido]pentanedioicacid
CAS Number
146464-95-1
Purity
≥ 98% (HPLC)
Molecular Formula
C23H23N7O5
Molecular Weight
477.48
MDL Number
MFCD00920897
PubChem ID
18350668
Melting Point
215 °C (dec.)
Appearance
White to light yellow powder to crystal
Conditions
Store at 2 - 8 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Pralatrexate is widely utilized in research focused on:

  • Cancer Treatment: Primarily used in the treatment of peripheral T-cell lymphoma, pralatrexate acts as an antifolate, inhibiting cancer cell growth by interfering with DNA synthesis.
  • Pharmaceutical Development: It serves as a critical compound in developing new cancer therapies, allowing researchers to explore combination treatments that enhance efficacy and reduce side effects.
  • Clinical Trials: Frequently involved in clinical studies, pralatrexate helps evaluate its effectiveness and safety in various cancer types, providing valuable data for oncologists.
  • Research on Drug Resistance: Utilized to study mechanisms of drug resistance in cancer cells, aiding in the development of strategies to overcome resistance and improve treatment outcomes.
  • Biomarker Identification: Plays a role in identifying biomarkers for patient stratification, helping clinicians tailor treatments based on individual responses to therapy.

Citations